1
|
Visani de Luna LA, Loret T, He Y, Legnani M, Lin H, Galibert AM, Fordham A, Holme S, Del Rio Castillo AE, Bonaccorso F, Bianco A, Flahaut E, Kostarelos K, Bussy C. Pulmonary Toxicity of Boron Nitride Nanomaterials Is Aspect Ratio Dependent. ACS Nano 2023; 17:24919-24935. [PMID: 38051272 PMCID: PMC10753895 DOI: 10.1021/acsnano.3c06599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Revised: 11/26/2023] [Accepted: 12/01/2023] [Indexed: 12/07/2023]
Abstract
Boron nitride (BN) nanomaterials have drawn a lot of interest in the material science community. However, extensive research is still needed to thoroughly analyze their safety profiles. Herein, we investigated the pulmonary impact and clearance of two-dimensional hexagonal boron nitride (h-BN) nanosheets and boron nitride nanotubes (BNNTs) in mice. Animals were exposed by single oropharyngeal aspiration to h-BN or BNNTs. On days 1, 7, and 28, bronchoalveolar lavage (BAL) fluids and lungs were collected. On one hand, adverse effects on lungs were evaluated using various approaches (e.g., immune response, histopathology, tissue remodeling, and genotoxicity). On the other hand, material deposition and clearance from the lungs were assessed. Two-dimensional h-BN did not cause any significant immune response or lung damage, although the presence of materials was confirmed by Raman spectroscopy. In addition, the low aspect ratio h-BN nanosheets were internalized rapidly by phagocytic cells present in alveoli, resulting in efficient clearance from the lungs. In contrast, high aspect ratio BNNTs caused a strong and long-lasting inflammatory response, characterized by sustained inflammation up to 28 days after exposure and the activation of both innate and adaptive immunity. Moreover, the presence of granulomatous structures and an indication of ongoing fibrosis as well as DNA damage in the lung parenchyma were evidenced with these materials. Concurrently, BNNTs were identified in lung sections for up to 28 days, suggesting long-term biopersistence, as previously demonstrated for other high aspect ratio nanomaterials with poor lung clearance such as multiwalled carbon nanotubes (MWCNTs). Overall, we reveal the safer toxicological profile of BN-based two-dimensional nanosheets in comparison to their nanotube counterparts. We also report strong similarities between BNNTs and MWCNTs in lung response, emphasizing their high aspect ratio as a major driver of their toxicity.
Collapse
Affiliation(s)
- Luis Augusto Visani de Luna
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| | - Thomas Loret
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| | - Yilin He
- CNRS,
Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University
of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Morgan Legnani
- CIRIMAT,
Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université
de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France
| | - Hazel Lin
- CNRS,
Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University
of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Anne Marie Galibert
- CIRIMAT,
Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université
de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France
| | - Alexander Fordham
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| | - Sonja Holme
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| | | | - Francesco Bonaccorso
- BeDimensional
S.p.A., Lungo Torrente
Secca 30r, 16163 Genoa, Italy
- Istituto
Italiano di Tecnologia, Graphene Laboratories, Via Morego 30, 16163 Genoa, Italy
| | - Alberto Bianco
- CNRS,
Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University
of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Emmanuel Flahaut
- CIRIMAT,
Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université
de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France
| | - Kostas Kostarelos
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Catalan
Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST,, Campus UAB, Bellaterra, 08193 Barcelona, Spain
| | - Cyrill Bussy
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science
Centre, Manchester M13 9PT, U.K.
- National
Graphene Institute, The University of Manchester, Manchester, M13 9PL, U.K.
- Lydia
Becker Institute of Immunology and Inflammation, Faculty of Biology,
Medicine and Health, The University of Manchester,
Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
| |
Collapse
|
2
|
Loret T, de Luna LAV, Lucherelli MA, Fordham A, Lozano N, Bianco A, Kostarelos K, Bussy C. Lung Persistence, Biodegradation, and Elimination of Graphene-Based Materials are Predominantly Size-Dependent and Mediated by Alveolar Phagocytes. Small 2023; 19:e2301201. [PMID: 37264768 DOI: 10.1002/smll.202301201] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Revised: 04/03/2023] [Indexed: 06/03/2023]
Abstract
Graphene-based materials (GBMs) have promising applications in various sectors, including pulmonary nanomedicine. Nevertheless, the influence of GBM physicochemical characteristics on their fate and impact in lung has not been thoroughly addressed. To fill this gap, the biological response, distribution, and bio-persistence of four different GBMs in mouse lungs up to 28 days after single oropharyngeal aspiration are investigated. None of the GBMs, varying in size (large versus small) and carbon to oxygen ratio as well as thickness (few-layers graphene (FLG) versus thin graphene oxide (GO)), induce a strong pulmonary immune response. However, recruited neutrophils internalize nanosheets better and degrade GBMs faster than macrophages, revealing their crucial role in the elimination of small GBMs. In contrast, large GO sheets induce more damages due to a hindered degradation and long-term persistence in macrophages. Overall, small dimensions appear to be a leading feature in the design of safe GBM pulmonary nanovectors due to an enhanced degradation in phagocytes and a faster clearance from the lungs for small GBMs. Thickness also plays an important role, since decreased material loading in alveolar phagocytes and faster elimination are found for FLGs compared to thinner GOs. These results are important for designing safer-by-design GBMs for biomedical application.
Collapse
Affiliation(s)
- Thomas Loret
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| | - Luis Augusto Visani de Luna
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| | - Matteo Andrea Lucherelli
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg, 67000, France
| | - Alexander Fordham
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, Barcelona, 08193, Spain
| | - Alberto Bianco
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg, 67000, France
| | - Kostas Kostarelos
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, Barcelona, 08193, Spain
| | - Cyrill Bussy
- Nanomedicine Lab 2.0, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
- National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
- Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK
| |
Collapse
|
3
|
de Luna LAV, Loret T, Fordham A, Arshad A, Drummond M, Dodd A, Lozano N, Kostarelos K, Bussy C. Lung recovery from DNA damage induced by graphene oxide is dependent on size, dose and inflammation profile. Part Fibre Toxicol 2022; 19:62. [PMID: 36131347 PMCID: PMC9490925 DOI: 10.1186/s12989-022-00502-w] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Accepted: 09/06/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND A key aspect of any new material safety assessment is the evaluation of their in vivo genotoxicity. Graphene oxide (GO) has been studied for many promising applications, but there are remaining concerns about its safety profile, especially after inhalation. Herein we tested whether GO lateral dimension, comparing micrometric (LGO) and nanometric (USGO) GO sheets, has a role in the formation of DNA double strand breaks in mouse lungs. We used spatial resolution and differential cell type analysis to measure DNA damages in both epithelial and immune cells, after either single or repeated exposure. RESULTS GO induced DNA damages were size and dose dependent, in both exposure scenario. After single exposure to a high dose, both USGO and LGO induced significant DNA damage in the lung parenchyma, but only during the acute phase response (p < 0.05 for USGO; p < 0.01 for LGO). This was followed by a fast lung recovery at day 7 and 28 for both GOs. When evaluating the chronic impact of GO after repeated exposure, only a high dose of LGO induced long-term DNA damages in lung alveolar epithelia (at 84 days, p < 0.05). Regardless of size, low dose GO did not induce any significant DNA damage after repeated exposure. A multiparametric correlation analysis of our repeated exposure data revealed that transient or persistent inflammation and oxidative stress were associated to either recovery or persistent DNA damages. For USGO, recovery from DNA damage was correlated to efficient recovery from acute inflammation (i.e., significant secretion of SAA3, p < 0.001; infiltration of neutrophils, p < 0.01). In contrast, the persistence of LGO in lungs was associated to a long-lasting presence of multinucleated macrophages (up to 84 days, p < 0.05), an underlying inflammation (IL-1α secretion up to 28 days, p < 0.05) and the presence of persistent DNA damages at 84 days. CONCLUSIONS Overall these results highlight the importance of the exposure scenario used. We showed that LGO was more genotoxic after repeated exposure than single exposure due to persistent lung inflammation. These findings are important in the context of human health risk assessment and toward establishing recommendations for a safe use of graphene based materials in the workplace.
Collapse
Affiliation(s)
- Luis Augusto Visani de Luna
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK.,Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK
| | - Thomas Loret
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK.,Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK
| | - Alexander Fordham
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK.,Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK
| | - Atta Arshad
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK.,Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK
| | - Matthew Drummond
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
| | - Abbie Dodd
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain
| | - Kostas Kostarelos
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK.,Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain
| | - Cyrill Bussy
- Nanomedicine Lab 2.0, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK. .,National Graphene Institute, The University of Manchester, Manchester, M13 9PL, UK. .,Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK.
| |
Collapse
|
4
|
Chortarea S, Kuru OC, Netkueakul W, Pelin M, Keshavan S, Song Z, Ma B, Gómes J, Abalos EV, Luna LAVD, Loret T, Fordham A, Drummond M, Kontis N, Anagnostopoulos G, Paterakis G, Cataldi P, Tubaro A, Galiotis C, Kinloch I, Fadeel B, Bussy C, Kostarelos K, Buerki-Thurnherr T, Prato M, Bianco A, Wick P. Hazard assessment of abraded thermoplastic composites reinforced with reduced graphene oxide. J Hazard Mater 2022; 435:129053. [PMID: 35650742 DOI: 10.1016/j.jhazmat.2022.129053] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/13/2022] [Revised: 04/22/2022] [Accepted: 04/29/2022] [Indexed: 06/15/2023]
Abstract
Graphene-related materials (GRMs) are subject to intensive investigations and considerable progress has been made in recent years in terms of safety assessment. However, limited information is available concerning the hazard potential of GRM-containing products such as graphene-reinforced composites. In the present study, we conducted a comprehensive investigation of the potential biological effects of particles released through an abrasion process from reduced graphene oxide (rGO)-reinforced composites of polyamide 6 (PA6), a widely used engineered thermoplastic polymer, in comparison to as-produced rGO. First, a panel of well-established in vitro models, representative of the immune system and possible target organs such as the lungs, the gut, and the skin, was applied. Limited responses to PA6-rGO exposure were found in the different in vitro models. Only as-produced rGO induced substantial adverse effects, in particular in macrophages. Since inhalation of airborne materials is a key occupational concern, we then sought to test whether the in vitro responses noted for these materials would translate into adverse effects in vivo. To this end, the response at 1, 7 and 28 days after a single pulmonary exposure was evaluated in mice. In agreement with the in vitro data, PA6-rGO induced a modest and transient pulmonary inflammation, resolved by day 28. In contrast, rGO induced a longer-lasting, albeit moderate inflammation that did not lead to tissue remodeling within 28 days. Taken together, the present study suggests a negligible impact on human health under acute exposure conditions of GRM fillers such as rGO when released from composites at doses expected at the workplace.
Collapse
Affiliation(s)
- Savvina Chortarea
- Swiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Ogul Can Kuru
- Swiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Woranan Netkueakul
- Swiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Marco Pelin
- Department of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | - Sandeep Keshavan
- Nanosafety & Nanomedicine Laboratory, Institute of Environmental Medicine, Karolinska Institutet, 177 77 Stockholm, Sweden
| | - Zhengmei Song
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Baojin Ma
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Julio Gómes
- Avanzare Innovacion Tecnologica S.L. 26370 Navarrete, Spain
| | - Elvira Villaro Abalos
- Instituto de Tecnologías Químicas de La Rioja (InterQuímica), 26370 Navarrete, Spain
| | - Luis Augusto Visani de Luna
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, United Kingdom; National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PL, United Kingdom
| | - Thomas Loret
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, United Kingdom; National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PL, United Kingdom
| | - Alexander Fordham
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, United Kingdom; National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PL, United Kingdom
| | - Matthew Drummond
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, United Kingdom; National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom
| | - Nikolaos Kontis
- Institute of Chemical Engineering Sciences, Foundation of Research and Technology-Hellas (FORTH/ICE-HT), 26504 Patras, Greece
| | - George Anagnostopoulos
- Institute of Chemical Engineering Sciences, Foundation of Research and Technology-Hellas (FORTH/ICE-HT), 26504 Patras, Greece
| | - George Paterakis
- Institute of Chemical Engineering Sciences, Foundation of Research and Technology-Hellas (FORTH/ICE-HT), 26504 Patras, Greece
| | - Pietro Cataldi
- National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Department of Materials, University of Manchester, Manchester M13 9PL, United Kingdom
| | - Aurelia Tubaro
- Department of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | - Costas Galiotis
- Institute of Chemical Engineering Sciences, Foundation of Research and Technology-Hellas (FORTH/ICE-HT), 26504 Patras, Greece; Department of Chemical Engineering, University of Patras, 26504 Patras, Greece
| | - Ian Kinloch
- National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Department of Materials, University of Manchester, Manchester M13 9PL, United Kingdom
| | - Bengt Fadeel
- Nanosafety & Nanomedicine Laboratory, Institute of Environmental Medicine, Karolinska Institutet, 177 77 Stockholm, Sweden
| | - Cyrill Bussy
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, United Kingdom; National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PL, United Kingdom
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, United Kingdom; National Graphene Institute, University of Manchester, Manchester M13 9PL, United Kingdom; Catalan Institute of Nanoscience and Nanotechnology (ICN2), and Barcelona Institute of Science and Technology (BIST), Barcelona 08193, Spain
| | - Tina Buerki-Thurnherr
- Swiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Maurizio Prato
- Department of Chemical and Pharmaceutical Sciences, University of Trieste, 34127 Trieste, Italy; Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia San Sebastián, Spain; Basque Foundation for Science (IKERBASQUE), 48013 Bilbao, Spain
| | - Alberto Bianco
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, ISIS, 67000 Strasbourg, France
| | - Peter Wick
- Swiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland.
| |
Collapse
|
5
|
Loret T, de Luna LAV, Fordham A, Arshad A, Barr K, Lozano N, Kostarelos K, Bussy C. Innate but Not Adaptive Immunity Regulates Lung Recovery from Chronic Exposure to Graphene Oxide Nanosheets. Adv Sci (Weinh) 2022; 9:e2104559. [PMID: 35166457 PMCID: PMC9008410 DOI: 10.1002/advs.202104559] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/14/2021] [Revised: 12/21/2021] [Indexed: 05/05/2023]
Abstract
Graphene has drawn a lot of interest in the material community due to unique physicochemical properties. Owing to a high surface area to volume ratio and free oxygen groups, the oxidized derivative, graphene oxide (GO) has promising potential as a drug delivery system. Here, the lung tolerability of two distinct GO varying in lateral dimensions is investigated, to reveal the most suitable candidate platform for pulmonary drug delivery. Following repeated chronic pulmonary exposure of mice to GO sheet suspensions, the innate and adaptive immune responses are studied. An acute and transient influx of neutrophils and eosinophils in the alveolar space, together with the replacement of alveolar macrophages by interstitial ones and a significant activation toward anti-inflammatory subsets, are found for both GO materials. Micrometric GO give rise to persistent multinucleated macrophages and granulomas. However, neither adaptive immune response nor lung tissue remodeling are induced after exposure to micrometric GO. Concurrently, milder effects and faster tissue recovery, both associated to a faster clearance from the respiratory tract, are found for nanometric GO, suggesting a greater lung tolerability. Taken together, these results highlight the importance of dimensions in the design of biocompatible 2D materials for pulmonary drug delivery system.
Collapse
Affiliation(s)
- Thomas Loret
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
- Lydia Becker Institute of Immunology and InflammationFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
| | - Luis Augusto Visani de Luna
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
- Lydia Becker Institute of Immunology and InflammationFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
| | - Alexander Fordham
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
- Lydia Becker Institute of Immunology and InflammationFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
| | - Atta Arshad
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
- Lydia Becker Institute of Immunology and InflammationFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
| | - Katharine Barr
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
| | - Neus Lozano
- Catalan Institute of Nanoscience and Nanotechnology (ICN2)CSIC and The Barcelona Institute of Science and Technology (BIST)Campus UABBellaterraBarcelona08193Spain
| | - Kostas Kostarelos
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2)CSIC and The Barcelona Institute of Science and Technology (BIST)Campus UABBellaterraBarcelona08193Spain
| | - Cyrill Bussy
- Nanomedicine LabFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteThe University of ManchesterManchesterM13 9PLUK
- Lydia Becker Institute of Immunology and InflammationFaculty of Biology, Medicine and HealthThe University of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
| |
Collapse
|
6
|
Terreros MJS, de Luna LAV, Giorgio S. Evaluation of antileishmanial drugs activities in an ex vivo model of leishmaniasis. Parasitol Int 2019; 71:163-166. [DOI: 10.1016/j.parint.2019.04.011] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2019] [Revised: 03/18/2019] [Accepted: 04/12/2019] [Indexed: 11/15/2022]
|
7
|
de Luna LAV, Zorgi NE, de Moraes ACM, da Silva DS, Consonni SR, Giorgio S, Alves OL. In vitro immunotoxicological assessment of a potent microbicidal nanocomposite based on graphene oxide and silver nanoparticles. Nanotoxicology 2018; 13:189-203. [PMID: 30451576 DOI: 10.1080/17435390.2018.1537410] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Graphene oxide (GO) and silver nanoparticles (AgNPs) can be formed into a hybrid nanomaterial, known as GOAg nanocomposite, which presents high antibacterial activity. The successful translation of this nanomaterial into medical use depends on critical information about its toxicological profile. In keeping with a Safe-by-design approach, we evaluated the immunotoxicity of GOAg using J774 and primary murine macrophages. The interaction between GOAg and macrophages was investigated with a scanning electron microscope (SEM). High-throughput technologies were employed to evaluate cell viability, apoptosis/necrosis, mitochondrial depolarization and lipid peroxidation. The inflammogenicity of nanomaterials was predicted after quantification of the cytokines IL-1β, TNF-α and IL-10 before and after stimulation with interferon-γ (IFN-γ). The ratio between CD80 and CD206 macrophage populations were also estimated. In addition, the production of nitric oxide (NO) was investigated. SEM surveys revealed the potential of GOAg to induce frustrated phagocytosis. GOAg induced a dose-dependent mitochondrial depolarization, apoptosis and lipid peroxidation to J774 macrophages. GOAg toxicity was not modified in an inflammatory microenvironment, but its toxicity was within the range of concentrations used in bacterial inactivation. GOAg did not induce primary macrophages to significantly produce inflammatory cytokines, and previous macrophage stimulation did not enhance GOAg inflammogenicity. Additionally, the pristine nanomaterials and GOAg do not shift macrophages polarization towards M1. Sublethal concentrations of GOAg did not impair macrophages NO production. Finally, we suggest options for improvement of GOAg nanocomposite in ways that may help minimize its possible adverse outcomes to human health.
Collapse
Affiliation(s)
- Luis Augusto Visani de Luna
- a Laboratory of Solid State Chemistry , Institute of Chemistry, University of Campinas , Campinas , Brazil.,b Department of Animal Biology , Laboratory of leishmaniasis, Institute of Biology, University of Campinas , Campinas , Brazil
| | - Nahiara Esteves Zorgi
- b Department of Animal Biology , Laboratory of leishmaniasis, Institute of Biology, University of Campinas , Campinas , Brazil
| | | | | | - Sílvio Roberto Consonni
- d Laboratory of Cytochemistry and Immunocytochemistry , Institute of Biology, University of Campinas , Campinas , Brazil
| | - Selma Giorgio
- b Department of Animal Biology , Laboratory of leishmaniasis, Institute of Biology, University of Campinas , Campinas , Brazil
| | - Oswaldo Luiz Alves
- a Laboratory of Solid State Chemistry , Institute of Chemistry, University of Campinas , Campinas , Brazil
| |
Collapse
|
8
|
Terreros MJS, de Luna LAV, Giorgio S. Long-term cell culture isolated from lesions of mice infected with Leishmania amazonensis: a new approach to study mononuclear phagocyte subpopulations during the infection. Pathog Dis 2017; 75:4554384. [DOI: 10.1093/femspd/ftx114] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2017] [Accepted: 10/13/2017] [Indexed: 11/14/2022] Open
|
9
|
de Luna LAV, de Moraes ACM, Consonni SR, Pereira CD, Cadore S, Giorgio S, Alves OL. Comparative in vitro toxicity of a graphene oxide-silver nanocomposite and the pristine counterparts toward macrophages. J Nanobiotechnology 2016; 14:12. [PMID: 26912341 PMCID: PMC4765018 DOI: 10.1186/s12951-016-0165-1] [Citation(s) in RCA: 44] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2015] [Accepted: 02/12/2016] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Graphene oxide (GO) is a highly oxidized graphene form with oxygen functional groups on its surface. GO is an excellent platform to support and stabilize silver nanoparticles (AgNP), which gives rise to the graphene oxide-silver nanoparticle (GOAg) nanocomposite. Understanding how this nanocomposite interacts with cells is a toxicological challenge of great importance for future biomedical applications, and macrophage cells can provide information concerning the biocompatibility of these nanomaterials. The cytotoxicity of the GOAg nanocomposite, pristine GO, and pristine AgNP was compared toward two representative murine macrophages: a tumoral lineage (J774) and peritoneal macrophages collected from Balb/c mouse. The production of reactive oxygen species (ROS) by J774 macrophages was also monitored. We investigated the internalization of nanomaterials by transmission electron microscopy (TEM). The quantification of internalized silver was carried out by inductively coupled plasma mass spectrometry (ICP-MS). Nanomaterial stability in the cell media was investigated overtime by visual observation, inductively coupled plasma optical emission spectrometry (ICP OES), and dynamic light scattering (DLS). RESULTS The GOAg nanocomposite was more toxic than pristine GO and pristine AgNP for both macrophages, and it significantly induced more ROS production compared to pristine AgNP. TEM analysis showed that GOAg was internalized by tumoral J774 macrophages. However, macrophages internalized approximately 60 % less GOAg than did pristine AgNP. The images also showed the degradation of nanocomposite inside cells. CONCLUSIONS Although the GOAg nanocomposite was less internalized by the macrophage cells, it was more toxic than the pristine counterparts and induced remarkable oxidative stress. Our findings strongly reveal a synergistic toxicity effect of the GOAg nanocomposite. The toxicity and fate of nanocomposites in cells are some of the major concerns in the development of novel biocompatible materials and must be carefully evaluated.
Collapse
Affiliation(s)
- Luis Augusto Visani de Luna
- Laboratory of Solid State Chemistry (LQES), Institute of Chemistry, University of Campinas, Campinas, Brazil.
- Laboratory of Leishmaniasis (Lableish), Institute of Biology, University of Campinas, Campinas, Brazil.
| | | | - Sílvio Roberto Consonni
- Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Brazil.
- Laboratory of Cytochemistry and Immunocytochemistry (LCI), Institute of Biology, University of Campinas, Campinas, Brazil.
| | - Catarinie Diniz Pereira
- Atomic Spectrometry Group (GEAtom), Institute of Chemistry, University of Campinas, Campinas, Brazil.
| | - Solange Cadore
- Atomic Spectrometry Group (GEAtom), Institute of Chemistry, University of Campinas, Campinas, Brazil.
| | - Selma Giorgio
- Laboratory of Leishmaniasis (Lableish), Institute of Biology, University of Campinas, Campinas, Brazil.
| | - Oswaldo Luiz Alves
- Laboratory of Solid State Chemistry (LQES), Institute of Chemistry, University of Campinas, Campinas, Brazil.
| |
Collapse
|